SynthesisBMC surgery2025
The role of postoperative ketamine infusion in ERAS protocols following elective open abdominal surgeries, a systematic review and meta-analysis.
Synthesis in BMC surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionEnhanced Recovery After Surgery (ERAS) protocols are multimodal, evidence-based pathways designed to accelerate postoperative recovery and reduce complications. A key component of ERAS is optimizing pain management to minimize opioid reliance. Ketamine, an NMDA receptor antagonist, has demonstrated potential as a multimodal analgesic for reducing opioid consumption and postoperative pain; however, its specific role and efficacy within comprehensive ERAS protocols remain under-evaluated, with variations in dosing and patient response. The current literature lacks a clear consensus on the efficacy of postoperative ketamine infusion for critical ERAS outcomes, including pain control, opioid consumption, postoperative nausea and vomiting (PONV), and length of hospital stay. This meta-analysis evaluates the impact of postoperative ketamine infusion on pain, opioid use, and recovery outcomes within ERAS protocols for elective open abdominal surgeries.
methodsA systematic review and meta-analysis were conducted by screening PubMed, Scopus, and EMBASE up to June 2024. Randomized controlled trials involving adult patients undergoing elective open abdominal surgery were included if they compared postoperative ketamine infusion with standard care or placebo within an ERAS setting. The primary outcomes were postoperative pain intensity, measured using the Visual Analog Scale (VAS), and opioid consumption, converted to morphine equivalents. The risk of bias was assessed using the Cochrane Risk of Bias 2 tool, and evidence quality was graded using the GRADE approach. A random-effects model was applied to account for heterogeneity across studies.
resultsFourteen RCTs involving 1067 patients met inclusion criteria. Ketamine significantly reduced postoperative pain scores (standardized mean difference - 0.53, 95% CI [-0.84, -0.22], p < 0.05) and opioid consumption within the first 24 h post-surgery (standardized mean difference - 0.44, 95% CI [-0.75, -0.13], p < 0.05) compared to control treatments. However, effects on PONV and other adverse events were not statistically significant (Log OR -0.19, 95% CI [-0.81, 0.43], p = 0.55), with considerable heterogeneity across studies (I² = 72.69%).
conclusionPostoperative ketamine infusion within ERAS protocols appears effective in reducing both pain and opioid consumption without significantly impacting PONV or adverse effects. These findings suggest ketamine may be a valuable adjunct in ERAS for elective open abdominal surgeries, though variability in results indicates that optimal dosing and administration strategies require further investigation to maximize patient recovery benefits and minimize side effects.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.